JXN Jackson Financial Inc.
Life Insurance · NYSE · SEC CIK 1822993 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY34.1%
TTM net income YoY53.6%
TTM EPS YoY70.3%
Revenue 3-yr CAGR53.6%
Net income 3-yr CAGR-20.8%
Margins
Gross margin—
Operating margin—
Net margin13.4%
FCF margin—
EBITDA margin—
Returns
ROE9.5%
ROA0.2%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets97.5%
Debt / equity0.33x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income6.70x
Accruals ratio-1.4%
Payout ratio27.0%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $6.68B | $3.27B | $3.08B | $9.85B | $6.36B |
| SG&A expense | $1.07B | $1.12B | $1.01B | $875.00M | $1.08B |
| Interest expense | $100.00M | $101.00M | $109.00M | $98.00M | $37.00M |
| Pretax income | -$114.00M | $1.02B | $958.00M | $7.73B | $4.05B |
| Income tax | -$186.00M | $46.00M | $4.00M | $1.50B | $666.00M |
| Net income | $27.00M | $946.00M | $934.00M | $6.19B | $3.42B |
| EPS (basic) | -0.24 | 11.86 | 10.99 | 72.34 | 36.35 |
| EPS (diluted) | -0.24 | 11.74 | 10.76 | 69.75 | 36.17 |
| Dividends declared per share | — | — | — | — | 0.50 |
| Weighted avg. shares (diluted) | 71.19M | 76.81M | 83.58M | 88.69M | 94.47M |
| Banking | |||||
| Loans, net | $10.21B | $9.91B | $10.56B | $10.97B | $11.48B |
| Balance sheet | |||||
| Cash & equivalents | $5.70B | $3.77B | $2.69B | $4.30B | $2.63B |
| Total assets | $352.59B | $338.45B | $330.25B | $314.98B | $375.56B |
| Short-term debt | — | — | $970.00M | $311.00M | — |
| Long-term debt | $2.03B | $2.03B | $2.04B | $2.63B | $2.65B |
| Total debt | $2.03B | $2.03B | $3.01B | $2.95B | $2.65B |
| Total liabilities | $342.24B | $328.47B | $319.92B | $305.61B | $364.49B |
| Shareholders' equity | $9.95B | $9.76B | $10.17B | $8.65B | $10.39B |
| Net debt | -$3.67B | -$1.73B | $319.00M | -$1.35B | $18.00M |
| Shares outstanding | 66.83M | 73.38M | 78.66M | 82.69M | 88.69M |
| Cash flow statement | |||||
| Operating cash flow | $5.76B | $5.79B | $5.31B | $5.21B | $5.68B |
| Investing cash flow | -$7.76B | -$7.09B | -$592.00M | -$1.37B | -$1.30B |
| Financing cash flow | $3.94B | $2.37B | -$6.33B | -$2.16B | -$3.77B |
| Depreciation & amortization | — | — | — | — | $11.00M |
| Stock-based compensation | $132.00M | $191.00M | $107.00M | $131.00M | $129.00M |
| Dividends paid | $223.00M | $211.00M | $201.00M | $186.00M | $50.00M |
| Share buybacks | $669.00M | $442.00M | $306.00M | $321.00M | $211.00M |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.